[Identification of up-regulated genes induced by angiotensin II in cardiac fibroblasts]

Xin-Feng Wang1, Guang-Dao Gao, Yu-Bai Yang

  • 1Department of Pathophysiology, Medical College of Xi'an Jiaotong University, Xi'an 710061, China.

Insights

Suppression subtractive hybridization identified 19 up-regulated genes in rat cardiac fibroblasts (CF) stimulated by angiotensin II (Ang II). This method aids in understanding cardiac remodeling mechanisms.

Area of Science:

  • Molecular Biology
  • Cardiovascular Research

Context:

  • Adult rat cardiac fibroblasts (CF) are crucial for cardiac structure and function.
  • Angiotensin II (Ang II) is a key regulator of cardiovascular homeostasis and a mediator of cardiac remodeling.
  • Understanding gene expression changes in CFs under Ang II stimulation is vital for elucidating cardiac remodeling pathways.

Purpose:

  • To identify novel genes that are up-regulated in adult rat cardiac fibroblasts (CF) upon stimulation with angiotensin II (Ang II).
  • To establish a subtractive cDNA library for detecting differentially expressed genes.
  • To validate the utility of suppression subtractive hybridization (SSH) for identifying Ang II-induced genes in CFs.

Summary:

  • Suppression subtractive hybridization (SSH) was employed to compare gene expression between Ang II-stimulated and unstimulated rat cardiac fibroblasts (CF).
  • A subtractive cDNA library was generated and screened, leading to the identification and sequencing of 19 up-regulated genes and 7 expressed sequence tags (ESTs).
  • The identified genes are associated with critical cellular processes including extracellular matrix, cell cycle, signal transduction, cytoskeleton, and metabolism.

Impact:

  • The study successfully demonstrates SSH as a sensitive technique for detecting and cloning up-regulated genes in CFs.
  • The identified genes provide new insights into the molecular mechanisms underlying Ang II-induced cardiac remodeling.
  • This research offers a foundation for further investigation into the role of these genes in cardiovascular disease pathogenesis.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Cellular Adaptation II: Hypertrophy01:26

Cellular Adaptation II: Hypertrophy

Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...